Business
NTRR: Cannabis Topicals Could Revolutionize Sports Training and Recovery
NTRR: Cannabis Topicals Could Revolutionize Sports Training and Recovery.
About this update from Neutra Corp.
[{"type":"text","content":"\n \n Muscle stiffness, soreness and fatigue are challenges that every athlete \n is all too familiar with. Now, with the help of its new joint venture \n partner, Neutra Corp. (OTCQB:NTRR) is working to deliver superior new \n solutions to the aches and pains faced by athletes every day.\n \n \n And the all-natural key to easing muscle discomfort and improving \n athletic performance, the company believes, is cannabis.\n \n \n “More and more athletes are turning to cannabis-infused topical products \n such as lotions, balm and sprays because they’re fast-acting, \n long-lasting and just plain effective,” said NTRR CEO Chris Brown. \n “There is no better all-natural treatment for workout-related pain \n relief, and the market for these products is projected to explode as the \n regulated cannabis industry continues to spread across North America.”\n \n \n Cannabis topicals have been lauded by athletes for their analgesic, \n anti-inflammatory and antimicrobial properties. As their usage spreads, \n their popularity grows—cannabis topicals could be on the verge of \n becoming standard post-workout treatments for athletes everywhere.\n \n \n NTRR has big plans to capitalize on the trend. Earlier this month, the \n company made a play to enter the booming market for innovative, \n cannabis-infused topical products by forming a joint venture with \n Oceanview Health Services Ltd., a Canadian nutraceuticals company \n focused on providing new medicinal solutions utilizing cannabinoids. In \n 2016, NTRR plans to deliver many new offerings for cannabis producers \n and consumers alike as demand for CBD products and services grows by the \n day.\n \n \n About Neutra Corp.\n \n \n Neutra Corp. is a healthy lifestyle company that specializes in the \n development and marketing of natural wellness solutions, including \n cannabis-related products. By providing a variety of new technologies \n designed to ensure safer, more reliable access to cannabis in approved \n markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals \n (OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. \n (OTCBB: EDXC), delivering technological advancements in the cultivation \n and processing of cannabis in approved markets. For investing \n information and performance data, please visit www.ne...